Coca-Cola Brews Up Stout Sales to Close Out FY21

The fourth quarter marked the first since the pandemic that away-from-home volumes exceeded 2019 levels.

Securities In This Article
Coca-Cola Co
(KO)

Fourth-quarter results showcased the strength of wide-moat Coca-Cola’s KO leading brand mix, with organic sales up 9% (reflecting a 10% benefit from price/mix). We recognize this was on top of weak marks a year ago (down 3%), when the firm’s operations (particularly its away-from-home sales) were thwarted by mobility restrictions to curb the spread of COVID-19. However, we think the tide is turning; the fourth quarter marked the first since the pandemic that away-from-home volumes exceeded 2019 levels. And impressively, this hasn’t come at the expense of the firm’s at-home business, where management qualitatively cited continued strength.

Profits decayed (the adjusted operating margin shrank 520 basis points to 22.1%), but we don’t harvest concerns, as Coca-Cola prudently funneled significant resources toward marketing (qualitatively referenced). From our vantage point, this illustrates it’s more focused on bolstering its competitive prowess than preserving near-term profits in the face of extensive inflation. Management pegs a commodity hit in the mid-single-digits in fiscal 2022, but we expect Coca-Cola will employ a combination of price hikes, price/pack architecture, and productivity initiatives to protect margins longer term. And despite the near-term angst, we think it maintains sufficient opportunity for operating margins to percolate--which we see reaching the low-30s--as it pursues efficiencies, optimizes its portfolio, and streamlines its technology infrastructure.

Management’s initial fiscal 2022 targets--7%-8% organic sales growth and 8%-10% adjusted EPS growth--seem attainable. When taken with fiscal 2021 results that generally aligned with our forecast, our $59 fair value estimate shouldn’t change, outside of a small uptick for time value and as we reverse our prior outlook for a step-up in U.S. corporate tax rates. But with the stock trading a touch above our intrinsic valuation, we don’t think investors should load up on shares at current levels.

Morningstar Premium Members gain exclusive access to our full analyst reports, including fair value estimates, bull and bear breakdowns, and risk analyses. Not a Premium Member? Get this and other reports immediately when you try Morningstar Premium free for 14 days.

More in Stocks

About the Author

Erin Lash, CFA

Sector Director
More from Author

Erin Lash, CFA, is a sector director, AM Consumer, for Morningstar*. In addition to leading the sector team, she covers packaged food and household and personal care companies. Beyond managing a team of nine analysts and associates covering an array of consumer firms, Lash also conducts fundamental analysis of 13 multi-billion-dollar market capitalization firms in the packaged food and household and personal care space.

Before joining Morningstar in 2006, Lash spent four years as an investment analyst covering retail, transportation, and technology firms for State Farm Insurance. In this capacity, Lash analyzed financial statements, business strategy, and fundamentals of owned companies and potential investments, presenting her recommendations based on this analysis to State Farm portfolio managers for ownership consideration.

Lash holds a bachelor’s degree in finance from Bradley University’s Foster College of Business. She also holds a master’s degree in business administration, with concentrations in accounting and finance, from the University of Chicago Booth School of Business. Lash has completed the Chartered Financial Analyst® designation. She ranked second in the food and tobacco industry in The Wall Street Journal’s annual “Best on the Street” analysts survey in 2013, the last year the survey was conducted.

* Morningstar Research Services LLC (“Morningstar”) is a wholly owned subsidiary of Morningstar, Inc

Sponsor Center